Clinical Site

Ann Arbor, Michigan 48109-5314

2 studies enrolling now · 5 studies all time

What they study most

Familial Partial Lipodystrophy, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Respiratory Syncytial Virus Infections

Studies at this site

• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed